These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1772 related articles for article (PubMed ID: 31063591)
1. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591 [TBL] [Abstract][Full Text] [Related]
2. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156 [TBL] [Abstract][Full Text] [Related]
3. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737 [TBL] [Abstract][Full Text] [Related]
4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Sep; 9(9):CD009219. PubMed ID: 27669661 [TBL] [Abstract][Full Text] [Related]
5. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; (8):CD010885. PubMed ID: 27498707 [TBL] [Abstract][Full Text] [Related]
6. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010885. PubMed ID: 31961948 [TBL] [Abstract][Full Text] [Related]
7. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2018 Jul; 7(7):CD010885. PubMed ID: 29975402 [TBL] [Abstract][Full Text] [Related]
8. Different infusion durations for preventing platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jun; (6):CD010885. PubMed ID: 24968257 [TBL] [Abstract][Full Text] [Related]
9. Platinum-induced hearing loss after treatment for childhood cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906 [TBL] [Abstract][Full Text] [Related]
10. Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines. de Baat EC; Mulder RL; Armenian S; Feijen EA; Grotenhuis H; Hudson MM; Mavinkurve-Groothuis AM; Kremer LC; van Dalen EC Cochrane Database Syst Rev; 2022 Sep; 9(9):CD014638. PubMed ID: 36162822 [TBL] [Abstract][Full Text] [Related]
11. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610 [TBL] [Abstract][Full Text] [Related]
12. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801 [TBL] [Abstract][Full Text] [Related]
13. Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. Peinemann F; Tushabe DA; van Dalen EC; Berthold F Cochrane Database Syst Rev; 2015 May; 2015(5):CD010774. PubMed ID: 25989478 [TBL] [Abstract][Full Text] [Related]